Eloxx Pharmaceuticals, Inc. is a pharmaceutical company filing a comprehensive Annual Report covering fiscal years 2023, 2024, and 2025 as part of efforts to become current in SEC filing obligations. The filing represents their first periodic SEC submission since a Form 10-Q filed November 13, 2023. Specific products, services, and business operations are not described in the provided Item 1 excerpt.
Q2 FY2026 — expected 2026-08-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-17 | 2025-12-31 | 0001193125-26-108687 | EDGAR | 110K words |
| 2023-03-31 | 2022-12-31 | 0000950170-23-011360 | EDGAR | — |
| 2022-03-30 | 2021-12-31 | 0001564590-22-012683 | EDGAR | — |
| 2021-03-12 | 2020-12-31 | 0001564590-21-012703 | EDGAR | — |
| 2020-03-06 | 2019-12-31 | 0001564590-20-009148 | EDGAR | — |
| 2019-03-14 | 2018-12-31 | 0001564590-19-007811 | EDGAR | — |
| 2018-03-16 | 2017-12-31 | 0001193125-18-086028 | EDGAR | — |
| 2017-10-13 | 2017-06-30 | 0001144204-17-052475 | EDGAR | — |
| 2016-10-13 | 2016-06-30 | 0001144204-16-128038 | EDGAR | — |
| 2015-10-09 | 2015-06-30 | 0001144204-15-058919 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2023-11-13 | 2023-09-30 | 0000950170-23-062940 | EDGAR | 48K words |
| 2023-08-11 | 2023-06-30 | 0000950170-23-041837 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0000950170-23-021821 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0000950170-22-024490 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001564590-22-029339 | EDGAR | — |
| 2022-05-06 | 2022-03-31 | 0001564590-22-018586 | EDGAR | — |
| 2021-11-08 | 2021-09-30 | 0001564590-21-055313 | EDGAR | — |
| 2021-08-16 | 2021-06-30 | 0001564590-21-044626 | EDGAR | — |
| 2021-05-07 | 2021-03-31 | 0001564590-21-025356 | EDGAR | — |
| 2020-11-06 | 2020-09-30 | 0001564590-20-051711 | EDGAR | — |
| 2020-08-07 | 2020-06-30 | 0001564590-20-038092 | EDGAR | — |
| 2020-05-08 | 2020-03-31 | 0001564590-20-023543 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2025-08-12 | 0001104659-25-076933 | EDGAR | 1K words |
| 2024-10-17 | 0001104659-24-109521 | EDGAR | — |
| 2024-07-16 | 0001104659-24-080251 | EDGAR | — |
| 2024-03-29 | 0001104659-24-041148 | EDGAR | — |
| 2024-03-14 | 0001104659-24-034529 | EDGAR | — |
| 2024-01-09 | 0001104659-24-002631 | EDGAR | — |
| 2023-12-28 | 0001104659-23-130052 | EDGAR | — |
| 2023-12-15 | 0001104659-23-126400 | EDGAR | — |
| 2023-11-13 | 0001104659-23-117308 | EDGAR | — |
| 2023-10-16 | 0001104659-23-109423 | EDGAR | — |
389 total filings indexed. 357 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001035354 |
| Ticker | ELOX |
| Exchange | OTC |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report